Network origin in Mary Lynch first degree
Entity | Entity type | Industry | |
---|---|---|---|
Panag Pharma, Inc.
Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mary Lynch via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Pharmaceuticals: Major | Founder | |
TETRA BIO-PHARMA INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Dalhousie University | College/University | Corporate Officer/Principal | |
International Cannabinoid Research Society | Director/Board Member | ||
The Canadian Consortium for the Investigation of Cannabinoids | Director/Board Member |
Statistics
International
Canada | 5 |
United States | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Operational
Corporate Officer/Principal | 4 |
Founder | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Most connected contacts
Insiders | |
---|---|
Melanie Kelly | 5 |
Melanie Kelly | 2 |
Christian Lehmann | 1 |
Orlando Hung | 1 |
- Stock Market
- Insiders
- Mary Lynch
- Company connections